Furthermore, silence of NRF2 by RNA interference or inhibition of NRF2 by trigonelline can enhance the killing effect of AS on drug-resistant head and neck cancer cells in vivo and in vitro [37]. Here, NFE2L2 is linked to head and neck cancer.